U&I Corporation (056090) - Cash Flow Conversion Efficiency
Based on the latest financial reports, U&I Corporation (056090) has a cash flow conversion efficiency ratio of -0.034x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.27 Billion ≈ $-2.21 Million USD) by net assets (₩94.87 Billion ≈ $64.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is U&I Corporation's balance sheet to measure how much of total assets are equity-financed.
U&I Corporation - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how U&I Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 056090 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
U&I Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of U&I Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
IG Group Holdings PLC
LSE:IGG
|
0.144x |
|
CombinedX AB
ST:CX
|
0.135x |
|
Sports Entertainment Group Ltd
AU:SEG
|
0.156x |
|
Prozone Realty Limited
NSE:PROZONER
|
0.044x |
|
Metrofile
JSE:MFL
|
0.237x |
|
Ribbon Acquisition Corp Unit
NASDAQ:RIBBU
|
-0.001x |
|
Algoltek Inc
TWO:6684
|
0.004x |
|
Airtasker Ltd
AU:ART
|
-0.050x |
Annual Cash Flow Conversion Efficiency for U&I Corporation (2015–2025)
The table below shows the annual cash flow conversion efficiency of U&I Corporation from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market value of U&I Corporation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩94.15 Billion ≈ $63.80 Million |
₩2.61 Billion ≈ $1.77 Million |
0.028x | +59.39% |
| 2024-12-31 | ₩86.77 Billion ≈ $58.80 Million |
₩1.51 Billion ≈ $1.02 Million |
0.017x | +142.08% |
| 2023-12-31 | ₩59.90 Billion ≈ $40.59 Million |
₩-2.48 Billion ≈ $-1.68 Million |
-0.041x | +55.52% |
| 2022-12-31 | ₩57.68 Billion ≈ $39.09 Million |
₩-5.36 Billion ≈ $-3.64 Million |
-0.093x | -306.66% |
| 2021-12-31 | ₩28.54 Billion ≈ $19.34 Million |
₩1.28 Billion ≈ $870.63K |
0.045x | -43.30% |
| 2020-12-31 | ₩27.09 Billion ≈ $18.36 Million |
₩2.15 Billion ≈ $1.46 Million |
0.079x | +242.79% |
| 2019-12-31 | ₩37.99 Billion ≈ $25.74 Million |
₩-2.11 Billion ≈ $-1.43 Million |
-0.056x | +26.25% |
| 2018-12-31 | ₩39.20 Billion ≈ $26.57 Million |
₩-2.95 Billion ≈ $-2.00 Million |
-0.075x | -165.54% |
| 2017-12-31 | ₩54.29 Billion ≈ $36.79 Million |
₩-1.54 Billion ≈ $-1.04 Million |
-0.028x | +52.66% |
| 2016-12-31 | ₩59.07 Billion ≈ $40.03 Million |
₩-3.54 Billion ≈ $-2.40 Million |
-0.060x | +14.63% |
| 2015-12-31 | ₩62.85 Billion ≈ $42.59 Million |
₩-4.41 Billion ≈ $-2.99 Million |
-0.070x | -- |
About U&I Corporation
CG MedTech Co.,Ltd. researches, develops, manufactures, and sale of orthopedic medical devices in the healthcare service market. The company offers headless screws, cortex screws, and K-wires and pin; Aspiron and Maxima anterior cervical plate systems for use in anterior interbody screw/plate fixation of the cervical spine; ANAX OCT spinal system, a device for spinal surgery; Velofix PEEK SA cerv… Read more